title: A simple Ultraviolet spectrophotometric method for the determination of etoricoxib in dosage formulations.
abstract: The present study was undertaken to develop a validated, rapid, simple, and low-cost ultraviolet (UV) spectrophotometric method for estimating Etoricoxib (ETX) in pharmaceutical formulations. The analysis was performed on λ max 233 nm using 0.1 M HCl as blank/diluent. The proposed method was validated on International Conference on Harmonization (ICH) guidelines including parameters as linearity, accuracy, precision, reproducibility, and specificity. The proposed method was also used to access the content of the ETX in two commercial brands of Indian market. Beer's law was obeyed in concentration range of 0.1-0.5 μg/ml, and the regression equation was Y = 0.418x + 0.018. The mean accuracy values for 0.1 μg/ml and 0.2 μg/ml concentration of ETX were found to be 99.76 ± 0.52% and 99.12 ± 0.84, respectively, and relative standard deviation (RSD) of interday and intraday was less than 2%. The developed method was suitable and specific to the analysis of ETX even in the presence of common excipients. The method was applied on two different marketed brands and ETX contents were 98.5 ± 0.56 and 99.33 ± 0.44, respectively, of labeled claim. The proposed method was validated as per ICH guidelines and statistically good results were obtained. This method can be employed for routine analysis of ETX in bulk and commercial formulations.
authors: Department of Pharmaceutical Chemistry, Central Facility of Instrumentation, College of Pharmacy, IFTM Lodipur-Rajput, Moradabad, India.
authors: Shipra
authors: S
authors: Singh
authors: Amrita
authors: A
authors: Mishra
authors: Anurag
authors: A
authors: Verma
authors: Ashoke K
authors: AK
authors: Ghosh
authors: Arun K
authors: AK
authors: Mishra
keywords: Etoricoxib; UV spectrometry; quality control; validation
references: J AOAC Int. 2010 May-Jun;93(3):783-6
references: 20629376
references: J Adv Pharm Technol Res. 2010 Jul;1(3):354-7
references: 22247871
references: J Sep Sci. 2008 Jan;31(1):169-76
references: 18069701
references: J Adv Pharm Technol Res. 2011 Jul;2(3):163-9
references: 22171313
references: J AOAC Int. 2006 Sep-Oct;89(5):1268-75
references: 17042175
references: Inflammopharmacology. 2007 Aug;15(4):175-8
references: 17701021
references: J Pharm Biomed Anal. 1999 Oct;21(1):221-6
references: 10701931
references: J Adv Pharm Technol Res. 2010 Jul;1(3):348-53
references: 22247870